JPRN-jRCT2080223747已完成2 期
The clinical study to evaluate the efficacy, safety, and pharmacokinetics of MD-0901 in pediatric patients with ulcerative colitis in remission.
MOCHIDA PHARMACEUTICAL CO., LTD0 个研究点目标入组 26 人开始时间: 2017年12月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 16age old（—）
- 性别
- All
入选标准
- •(1)Subjects who are diagnosed as ulcerative colitis
- •(2)Subjects who are total score of 2 or less on the Ulcerative Colitis Disease Activity Index (UC-DAI) with a rectal bleeding score of 0 at the baseline
- •(3)Body weight 18-90 kg at the baseline
排除标准
- •(1)Subjects with a history of colectomy (except appendectomy)
- •(2)Subjects with moderate/severe renal or liver impairment
- •(3)Subjects with serious blood disorder, respiratory disorder, digestive disorder, cardiovascular disorder, psychiatric disorder, abnormal electrolyte metabolism disorder or hypersensitivity as complication
- •(4)Subjects with malignant tumor as complication
研究者
相似试验
已完成
2 期
Active phase study of MD-0901 in pediatric ulcerative colitis.Mildly to moderately active ulcerative colitisJPRN-jRCT2080223746MOCHIDA PHARMACEUTICAL CO., LTD26
已完成
不适用
A clinical study for evaluating efficacy and safety of long-term consumption -Double-blind, placebo-controlled parallel-group comparative, efficacy and safety of long-term verification study taking 1 times the dose of test food mainly composed of "ECM-E" that is an extract of chicken crests containing hyaluronic acid.JPRN-UMIN000026569Adaptgen Pharmaceutical Co., Ltd.45
已完成
不适用
A clinical study for evaluating efficacy and safety of long-term consumptioHealthy adultsJPRN-UMIN000027410Sun- O International Co., Ltd.30
已完成
3 期
A clinical Trial in patients with Vernal Keratoconjunctivitis. Clinical trial is to study efficacy, safety and tolerability of Tacrolimus Ophthalmic Suspension in comparison to Cyclosporine eye drops (reference product).CTRI/2010/091/001456Ajanta Pharma Ltd200
未知
2 期
S-304 PAHJPRN-jRCT2080221493IPPON SHINYAKU CO., LTD. / Actelion Pharmaceuticals Japan Ltd.30